Evidence map›Paper›PMID 27355213›Full record

ArticlePloS one2016

Predicting Response Trajectories during Cognitive-Behavioural Therapy for Panic Disorder: No Association with the BDNF Gene or Childhood Maltreatment.

Martí Santacana, Bárbara Arias, Marina Mitjans, Albert Bonillo, María Montoro, Sílvia Rosado, Roser Guillamat, Vicenç Vallès, Víctor Pérez, Carlos G Forero and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Martí SantacanaDepartment of Mental Health, Consorci Sanitari de Terrassa, Terrassa, Spain.
Bárbara AriasAnthropology Unit, Department of Animal Biology, Universitat de Barcelona, Barcelona, Spain.
Marina MitjansCIBERSAM (Centro de Investigaciones Biomédicas en Red de Salud Mental), Instituto de Salud Carlos III, Madrid, Spain.
Albert BonilloDepartment of Psychobiology and Methodology of Health Sciences, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain.
María MontoroDepartment of Mental Health, Consorci Sanitari de Terrassa, Terrassa, Spain.
Sílvia RosadoInstitute of Neuropsychiatry and Addictions, Hospital del Mar, Barcelona, Spain.
Roser GuillamatDepartment of Mental Health, Consorci Sanitari de Terrassa, Terrassa, Spain.
Vicenç VallèsDepartment of Mental Health, Consorci Sanitari de Terrassa, Terrassa, Spain.
Víctor PérezCIBERSAM (Centro de Investigaciones Biomédicas en Red de Salud Mental), Instituto de Salud Carlos III, Madrid, Spain.
Carlos G ForeroCIBERESP (Centro de Investigaciones Biomédicas en Red, Epidemiología y Salud Pública), Instituto de Salud Carlos III, Madrid, Spain.
Miquel A FullanaDepartment of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain.
Consorci Sanitari de Terrassa · ESUniversitat Autònoma de Barcelona · ESCentro de Investigación Biomédica en Red de Salud Mental · ESHospital Del Mar · ESHospital del Mar Research Institute · ESInstituto de Salud Carlos III · ESUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAnxiety disorders are highly prevalent and result in low quality of life and a high social and economic cost. The efficacy of cognitive-behavioural therapy (CBT) for anxiety disorders is well established, but a substantial proportion of patients do not respond to this treatment. Understanding which genetic and environmental factors are responsible for this differential response to treatment is a key step towards "personalized medicine". Based on previous research, our objective was to test whether the BDNF Val66Met polymorphism and/or childhood maltreatment are associated with response trajectories during exposure-based CBT for panic disorder (PD).

methodWe used Growth Mixture Modeling to identify latent classes of change (response trajectories) in patients with PD (N = 97) who underwent group manualized exposure-based CBT. We conducted logistic regression to investigate the effect on these trajectories of the BDNF Val66Met polymorphism and two different types of childhood maltreatment, abuse and neglect.

resultsWe identified two response trajectories ("high response" and "low response"), and found that they were not significantly associated with either the genetic (BDNF Val66Met polymorphism) or childhood trauma-related variables of interest, nor with an interaction between these variables.

conclusionsWe found no evidence to support an effect of the BDNF gene or childhood trauma-related variables on CBT outcome in PD. Future studies in this field may benefit from looking at other genotypes or using different (e.g. whole-genome) approaches.

Indexed as

Child AbuseCognitive Behavioral TherapyAdolescentAdultBrain-Derived Neurotrophic FactorFemaleGenetic VariationGenome, HumanGenotypeHumansMaleMiddle AgedModels, StatisticalPanic DisorderPolymorphism, GeneticPsychotherapy, GroupBDNF protein, humanBrain-Derived Neurotrophic Factor

Identifiers

PMID27355213
PMCPMC4927091
OpenAlexW2464165726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.